A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Clinical trial NCT05159752 · UNKNOWN
Trial details
- NCT number
- NCT05159752
- Sponsor
- Clinuvel Europe Limited
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2024-03-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.